Kovack Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Kovack Advisors's JAZZ Position: Q3 2026 in Review
Kovack Advisors held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2026 at 921 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #950.
Kovack Advisors first reported a position in JAZZ in Q4 2014 and has held it in 16 quarters since. The position peaked at $9.09M in Q4 2025. 668 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Kovack Advisors held 921 shares of Jazz Pharmaceuticals worth $214K as of Q3 2026.
- Kovack Advisors left its Jazz Pharmaceuticals share count unchanged in Q3 2026.
- Jazz Pharmaceuticals made up 0.01% of Kovack Advisors's portfolio in Q3 2026, its #950 holding.
- Kovack Advisors first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 16 quarters since.
- Kovack Advisors's Jazz Pharmaceuticals position peaked at $9.09M in Q4 2025.
- 668 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Kovack Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.